AbbVie Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $131.12B | $146.53B | $9.75B |
| FY2022 | $121.55B | $138.81B | $9.20B |
| FY2023 | $124.35B | $134.71B | $12.81B |
| FY2024 | $131.84B | $135.16B | $5.52B |
| FY2025 | $137.23B | $133.96B | $5.23B |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $131.12B | $146.53B | $9.75B |
| FY2022 | $121.55B | $138.81B | $9.20B |
| FY2023 | $124.35B | $134.71B | $12.81B |
| FY2024 | $131.84B | $135.16B | $5.52B |
| FY2025 | $137.23B | $133.96B | $5.23B |